The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: A single-blind, placebo-controlled, crossover clinical study-Reference-Cited by-同舟云学术

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: A single-blind, placebo-controlled, crossover clinical study

Published:2002-09 Issue:3 Volume:110 Page:484-488
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Erbagci Zülal

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Chronic urticaria: pathophysiology and treatment approaches;Tharp;J Allergy Clin Immunol,1996

2. The pathogenesis of chronic idiopathic urticaria;Sabroe;Arch Dermatol,1997

3. Montelukast;Markham;Drugs,1998

4. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults;Capella;Eur J Dermatol,2001

5. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis;Carucci;Arch Dermatol,1998

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urticaria Management in North America: What We Know and What We Do Not Know;Current Treatment Options in Allergy;2024-08-06

2. Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials;Journal of Allergy and Clinical Immunology;2024-06

3. The Key Points and Therapeutic Experience of Urticaria;Advances in Clinical Medicine;2023

4. Efficacy and safety of medications for antihistamine-refractory chronic spontaneous urticaria: a systematic review and network meta-analysis;Allergo Journal International;2022-12-21

5. Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study;The Journal of Allergy and Clinical Immunology: In Practice;2022-12